<DOC>
	<DOC>NCT02862288</DOC>
	<brief_summary>The aims of this work were to assess the feasibility, efficacy, short-term outcome and safety of microwave ablation in the treatment of malignant bone, lung and renal tumors.</brief_summary>
	<brief_title>Preliminary Study of Microwave Tumoral Ablation Performances for the Treatment of Pulmonary, Renal and Bone Neoplasia.</brief_title>
	<detailed_description />
	<mesh_term>Kidney Neoplasms</mesh_term>
	<criteria>Men and women &gt; 18 years old Thermoablation indication of renal neoplasia, bone or lung decided during a multidisciplinary consultation meeting Generally speaking, the indications are: (i) inoperable primary malignant tumor or secondary malignant tumor, (ii) resectable primary malignant renal and lung tumor with medical contraindication to surgery or general anesthesia Signature of informed consent for participation Affiliation to a social security scheme or French beneficiary of such a regime. Contraindication to percutaneous thermoablation Renal or lung tumor up to 4 cm Women of childbearing age, premenopausal, nonsterilized surgically, and unwilling to use effective contraception Legal incapacity or legal capacity limited Person unlikely to cooperate in the study and / or low degree of cooperation expected by the investigator Person without health insurance Pregnant women</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>